Latest Sustainable Investing News

L1 Group Limited delivered a standout FY26 with statutory profit up 79% and underlying net profit nearly doubling, driven by merger synergies and strong fund performance.

Global X Metal Securities Australia Limited has issued a prospectus for five classes of securities tracking gold, silver, platinum, palladium, and a precious metals basket. The securities are physically backed, traded on ASX under AQUA Rules, and managed by JPMorgan Chase Bank.

Light & Wonder's Q2 2026 sees net income jump 26% to $120 million, driven by strong Gaming and iGaming growth. The company sticks to its 2026 outlook, targeting mid- to high-single-digit EBITDA growth and aims to reduce leverage below 3.0x by mid-2027.

Australian Ethical reached a new record of $14.5 billion funds under management at June 30, 2026, driven by strong superannuation inflows and strategic investments amid challenging market conditions.

Orthocell Ltd delivered a standout FY26 with 44% revenue growth to A$13.2 million, powered by accelerating US sales of its nerve repair product Remplir and a robust cash position supporting further expansion.

Super Retail Group is gearing up to expand its store network and accelerate digital transformation through its new five-year strategy and Ignite program, aiming to capture a larger share of a $65 billion market opportunity.

Templeton Emerging Markets Investment Trust (TEMIT) posted a robust 41.3% net asset value total return for FY2026, outpacing its benchmark and narrowing its share price discount, while maintaining dividends and expanding share buybacks.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.

Urbanise.com Limited appoints Darc Rasmussen as Executive Chairman, unveils an AI Assistant for strata managers, and converts two legacy system customers with new contracts worth $700k over three years.

Orezone Gold’s acquisition of the Casa Berardi mine propels it into a diversified mid-tier producer, while Q1 2026 results show a 35% jump in gold output and robust financials despite operational challenges at Bomboré.

Boom Logistics has upgraded its FY26 earnings guidance, anticipating a 31% rise in statutory EPS, backed by $7 million in new contracts across energy and mining sectors.

Neuren Pharmaceuticals reported a solid A$30.4 million net profit in 2025, powered by a 15% rise in DAYBUE® royalties. The company is progressing its NNZ-2591 Phase 3 trial for Phelan-McDermid syndrome and has initiated a share buy-back amid perceived undervaluation.